Peripheral Neuropathy Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- People who have had a spinal cord injury for more than one year and whose condition is neurologically stable.
- People who have received medical clearance from a doctor to participate in the trial.
- People who are able to stand, with or without a walking aid or support device, for at least 3 minutes at a time.
- People whose current medications are expected to remain unchanged for at least 3 months (stable use of anti-spasticity medication is acceptable).
- For people with nerve pain, the area of nerve pain must include the lower leg.
Who may not be able to join:
- People who have an injury affecting the motor neurons (the nerve cells that directly control muscle movement).
- People with a known heart condition.
- People with a medically unstable condition, including those who are pregnant.
- People with cognitive impairment (difficulties with thinking, memory, or understanding).
- People with peripheral neuropathy (nerve damage in the limbs) that is not well controlled.
- People who frequently use electrical spinal stimulation — either through the skin or surgically implanted — for pain management.
- People who use electrical stimulation to the leg on a daily basis.
- People who have a complete absence of skin sensation around the foot.
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Principal Investigator: Aiko Thompson, PhD, Medical University of South Carolina
Phone: 843-792-6313
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
Change in minimum stimulation intensity required to barely detect the sensation (perceived threshold, perT); Change in minimum intensity at which the sensation covers the maximum area of skin (radiating threshold, RT); Change in minimum intensity at which the stimulus become painful (pain threshold, PainT); Change in pain as measured by the McGill Pain Questionnaire (MPQ); Change in neuropathic pain as measured by the Neuropathic Pain Symptom Inventory (NPSI)
Can't join this trial?
Data last synced from ClinicalTrials.gov: 15 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.